Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux

mdmcdonald

MDMcDonald_me_com

mike kraft

Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

U.S. Health Officials Question AstraZeneca Vaccine Trial Results

Tue, 2021-03-23 09:27 — mike kraft

Federal health officials said early Tuesday that results from a U.S. trial of AstraZeneca’s Covid-19 vaccine may have relied on “outdated information” that “may have provided an incomplete view of the efficacy data,” casting doubt on an announcement on Monday that had been seen as good news for the British-Swedish company as well as the global vaccination drive.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. Health Officials Question AstraZeneca Vaccine Trial Results
Log in or register to post comments

J&J Covid-19 vaccine still expected to reach target despite stalled supplies

Mon, 2021-03-22 20:24 — mike kraft

White House promises more J&J COVID-19 shots after launch stalls Johnson & Johnson should come close to hitting its target of delivering 20 million doses of its one-shot COVID-19 vaccine in March after its shipments stalled in recent weeks, a top White House official said on Monday, while declining to say how many will go out this week. Carl O’Donnell, Michael Erman U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about J&J Covid-19 vaccine still expected to reach target despite stalled supplies
Log in or register to post comments

California among worst states in getting vaccines to vulnerable populations: CDC report

Mon, 2021-03-22 20:06 — mike kraft

California among worst in getting vaccines to vulnerable populations, CDC report finds A CDC report found most of California's vaccines have gone to residents who don't face as many vulnerability factors such as race, education, poverty level and housing, ABC News ABC News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about California among worst states in getting vaccines to vulnerable populations: CDC report
Log in or register to post comments

U.S. meat plant workers in many states are finally gettng vaccinations

Mon, 2021-03-22 19:49 — mike kraft

Employees at food processing facilities, which had some of the country’s largest known coronavirus outbreaks early in the pandemic, are now eligible for vaccines in at least 26 states, a New York Times survey found.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. meat plant workers in many states are finally gettng vaccinations
Log in or register to post comments

The known covid variants have not reached the threshold of "variant of high consequence," CDC says

Mon, 2021-03-22 19:33 — mike kraft

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about The known covid variants have not reached the threshold of "variant of high consequence," CDC says
Log in or register to post comments

OVERVIEW: International and U.S. Covid-19 briefs--AP

Mon, 2021-03-22 18:55 — mike kraft

The Latest: Spain to offer AstraZeneca shot to adults 18-65 MADRID — Spain’s health minister said the country will resume use of the AstraZeneca vaccine against COVID-19 by extending it to adults up to 65 years of age and that authorities will consider... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: International and U.S. Covid-19 briefs--AP
Log in or register to post comments

OPINION: How can we get people to trust the AstraZeneca and other vaccines?

Mon, 2021-03-22 10:29 — mike kraft

News Update: A U.S. trial found that AstraZeneca’s vaccine was 79 percent effective with no serious side effects, according to results released on Monday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about OPINION: How can we get people to trust the AstraZeneca and other vaccines?
Log in or register to post comments

Myths and Facts about coronavirus vaccines -Washington Post

Mon, 2021-03-22 10:07 — mike kraft

Perspective | Five myths about coronavirus vaccines No, the mRNA vaccines don’t change your DNA Peter Hotez, Maria Elena Bottazzi Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Myths and Facts about coronavirus vaccines -Washington Post
Log in or register to post comments

J&J’s immunizations seems to be lagging

Mon, 2021-03-22 09:47 — mike kraft

Vaccine mystery: Why J&J’s shots aren’t reaching more arms The single-shot vaccine was supposed to be the catalyst for the country’s return to normalcy. Instead, it’s sparking confusion and finger-pointing. POLITICO

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about J&J’s immunizations seems to be lagging
Log in or register to post comments

AstraZeneca vaccine protects fully against Covid-19’s worst outcomes, new study shows.

Mon, 2021-03-22 09:16 — mike kraft

AstraZeneca: US data shows vaccine effective for all ages LONDON (AP) — AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease across all age groups in a late-stage study in... AP NEWS

LONDON (AP) — AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease across all age groups in a late-stage study in the United States, the company announced Monday.

Country / Region Tags:

General Topic Tags: